Skip to main content
SpringerLink
Log in

A Multicentre, Randomised, Double-Blind Study to Compare the Efficacy and Tolerability of Dexketoprofen Trometamol versus Diclofenac in the Symptomatic Treatment of Knee Osteoarthritis

  • Clinical Use
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

Abstract

Background: Dexketoprofen trometamol (DKP.TRIS) is the tromethamine salt of dexketoprofen, the S-enantiomer responsible for the pharmacological activity of ketoprofen. DKP.TRIS has rapid absorption and onset of action in pain relief.

Objective: To compare the efficacy and tolerability of DKP.TRIS and diclofenac, a nonsteroidal anti-inflammatory drug widely accepted as reference therapy for symptomatic treatment of osteoarthritis, in patients with chronic pain due to knee osteoarthritis.

Design: This was a multicentre, randomised, comparative, double-blind study.

Methods: Radiological evidence of osteoarthritis, shown by the presence of Kellgren grade 2 to 4 changes, was required. Patients were evaluated before and after a washout period of 7 to 14 days and after 1 and 2 weeks of treatment with DKP.TRIS 25mg three times daily orally or diclofenac 50mg three times daily orally. Primary end-points were reduction of pain measured on a visual analogue scale (VAS, 0 to 100mm) and disability measured by the Lequesne index of severity for knee osteoarthritis (ISK). Tolerability was evaluated by laboratory parameters and frequency and nature of adverse events.

Results: Of 117 patients recruited to the study, 115 were treated (61 with DKP.TRIS, 54 with diclofenac) and 99 (54/45) completed the 2-week treatment period. Patient characteristics were homogenous between groups. Pain measured on the VAS decreased by 43% from 61.7 ± 18.5mm (mean ± SD) at baseline to 34.7 ± 22.3mm at the end of treatment with DKP.TRIS compared with a 29% decrease from 62.1 ± 22.7mm to 40.6 ± 22.2mm for diclofenac [p = 0.027; 95% confidence interval (CI) for the difference between treatments: 1.7, 27.9]. Median ISK scores improved from 11 (range 9 to 12) to 8 (6 to 10) in the DKP.TRIS group versus 10.75 (9 to 12.5) to 8.5 (6 to 10.5) in the diclofenac group. There were no group differences for secondary end-points. Adverse events were comparable overall between groups.

Conclusion: Oral DKP.TRIS 25mg three times daily is at least as effective as diclofenac 50mg three times daily for the short term treatment of pain in patients with osteoarthritis of the knee.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Fig. 1
Table II
Fig. 2
Fig. 3
Table III

Similar content being viewed by others

References

  1. Swedberg JA. Osteoarthritis. Am Fam Physician 1992; 45: 557–68

    PubMed  CAS  Google Scholar 

  2. Al Arfag A, Davis P. Osteoarthritis: current drug treatment regimens. Drugs 1991; 41(2): 193–201

    Article  Google Scholar 

  3. Mauleön D, Artigas R, Garcia ML, et al. Preclinical and clinical development of dexketoprofen. Drugs 1996; 52Suppl. 5: 24–46

    Article  PubMed  Google Scholar 

  4. Beltrán J, Martín Mola E, Figueroa M, et al. Comparison of dexketoprofen trometamol and ketoprofen in the treatment of osteoarthritis of the knee. J Clin Pharmacol 1998; 38Suppl. 18: 74–80

    Google Scholar 

  5. Ezcurdia M, Cartejoso FJ, Lanzön R, et al. Comparison of the efficacy and tolerability of dexketoprofen and ketoprofen in the treatment of primary dysmenorrhea. J Clin Pharmacol 1998; 38Suppl. 18: 65–73

    Google Scholar 

  6. Gay C, Planas E, Donado M, et al. Analgesic effect of low doses of dexketoprofen in the dental pain model: a randomised, double-blind, placebo-controlled study. Clin Drug Invest 1996; 11:320–30

    Article  CAS  Google Scholar 

  7. McGurk M, Robinson P, Rajayogeswaran V, et al. Clinical comparison of dexketoprofen trometamol, ketoprofen, and placebo in postoperative dental pain. J Clin Pharmacol 1998; 38Suppl. 18: 46–54

    Google Scholar 

  8. Bagán JV, López Arranz JS, Valencia E, et al. Clinical comparison of dexketoprofen trometamol and dipyrone in postoperative dental pain. J Clin Pharmacol 1998; 38Suppl. 18: 55–64

    Google Scholar 

  9. Veys EM. 20 years’ experience with ketoprofen. Scand J RheumatolSuppl. 1991; 90Suppl. 1: 1–44

    Article  Google Scholar 

  10. Food and Drug Administration, US Department of Health and Human Services. Guidelines for the clinical evaluation of analgesic drugs. Bathesda (MD): Food and Drug Administration, 1992

    Google Scholar 

  11. British Medical Association and the Royal Pharmaceutical Association of Great Britain. Drugs used in the treatment of musculoskeletal and joint diseases. British National Formulary (London) 1996; 31: 403–25

    Google Scholar 

  12. European League Against Rheumatism. Guidelines for the clinical investigation of drugs used in rheumatic diseases. WHO Regional Office for Europe, Copenhagen, Denmark, March 1985

  13. Food and Drug Administration, US Department of Health and Human Services. Guidelines for the clinical evaluation of anti-inflammatory and antirheumatic drugs (adults and children). Bethesda (MD):Food and Drug Administration, 1988

    Google Scholar 

  14. Lequesne MG, Mery C, Samson M, et al. Indexes of severity for osteoarthritis of the hip and knee. Validation — value in comparison with other assessment tests. Scand J Rheumatol Suppl. 1987; 65: 85–9

    Article  CAS  Google Scholar 

  15. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthritis. Am J Rheum Dis 1957; 16: 494–501

    Article  CAS  Google Scholar 

  16. Bellamy N, Carette S, Ford PM. Osteoarthritis antirheumatic drug trials. I. Effects of standardization procedures on observer-dependent outcome measures. J Rheumatol 1992; 19: 436–43

    PubMed  CAS  Google Scholar 

  17. Bellamy N, Carette S, Ford PM. Osteoarthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials. J Rheumatol 1992; 19: 444–50

    PubMed  CAS  Google Scholar 

  18. Bellamy N, Carette S, Ford PM. Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials. J Rheumatol 1992; 19:451–7

    PubMed  CAS  Google Scholar 

  19. Dupont WD. Power and sample size calculations: a review and computer program. Control Clin Trials 1990; 11: 116–28

    Article  PubMed  CAS  Google Scholar 

  20. Carné X, Moreno V, Porta Serra M, et al. Epidemiología para clínicos: El cálculo del núméro de pacientes necessarios en la planificación de un estudio clínico. Med Clin (Barc) 1989; 92: 72–7

    Google Scholar 

  21. Kantor TG, Furst DE. Osteoarthritis. In: Max MB, Portenoy RK, Laska EM, editors. Advances in pain research and therapy. New York: Raven Press, 1991: 305–15

    Google Scholar 

  22. Caldwell J, Hutt AJ, Fournel-Gigleux S. The metabolic chiral inversion and dispositional enantioselectivity of the 2-aryl-propionic acids and their biological consequences. Biochem Pharmacol 1988; 37: 105–14

    Article  PubMed  CAS  Google Scholar 

  23. Cooper SA. Ketoprofen in oral surgery pain: a review. J Clin Pharmacol 1988; 28 (12 Suppl.): 40–6

    Google Scholar 

  24. Hayball P, Nation RL, Bochner F. Enantioselective pharmacodynamics of the nonsteroidal antiinflammatory drug ketoprofen: in vitro inhibition of human platelet cyclo-oxygenase activity. Chirality 1992; 4: 484–7

    Article  PubMed  CAS  Google Scholar 

  25. Suesa N, Fernández MF, Gutiérrez M, et al. Stereoselective cyclooxygenase inhibition in cellular models by the en-antiomers of ketoprofen. Chirality 1993; 5: 589–95

    Article  PubMed  CAS  Google Scholar 

  26. McCormack K, Urquhart E. Correlation between nonsteroidal anti-inflammatory drug efficacy in a clinical pain model and the dissociation of their anti-inflammatory and analgesic properties in animal models. Clin Drug Invest 1995; 9: 88–97

    Article  CAS  Google Scholar 

  27. Barbanoj MJ, Gich I, Artigas R, et al. Pharmacokinetics of dexketoprofen trometamol in healthy volunteers after single and repeated doses. J Clin Pharmacol 1998; 38Suppl. 18: 73–80

    Google Scholar 

  28. McEwen J, De Luca M, Casini A, et al. The effect of food and an antacid on the bioavailability of dexketoprofen trometamol.J Clin Pharmacol 1998; 38Suppl. 18: 41–5

    Google Scholar 

  29. Fosslien E. Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system. Ann Clin Lab Sci 1998; 28: 67–81

    PubMed  CAS  Google Scholar 

  30. Singh G, Ramey DR. NSAID induced gastrointestinal complications: the ARAMIS perspective — 1997. J Rheumatol 1998; 25Suppl. 51:8–16

    Google Scholar 

  31. Scheiman JM. NSAIDS and GI injury. Pt I. Epidemiology and pathogenesis. Drugs Today 1997; 33: 499–508

    Google Scholar 

  32. Insel PA. Analgesic-antipyretics and antiinflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout. In: Goodman S, Gilman A, Rall T, Nies AS, et al., editors. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. New York: Pergamon Press, 1990: 638–81

    Google Scholar 

  33. Hawkey C, Kahan A, Steinbrück K, et al., International Melissa Study Group. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. Br J Rheumatol 1998; 37: 937–45

    Article  PubMed  CAS  Google Scholar 

  34. Porto A, Reis C, Perdigoto B, et al. Gastroduodenal tolerability of nimesulide and diclofenac in patients with osteoarthritis. Curr Ther Res 1998; 59: 654–65

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by Laboratorios Menarini SA, Barcelona, Spain.

Author information

Authors and Affiliations

  1. Hospital Universitario de Valme, Seville, Spain

    J. L. Marenco

  2. Complejo Hospitalario ‘Carlos Haya’, Malaga, Spain

    M. Pérez

  3. Hospital General Universitario de Elche, Alicante, Spain

    F. J. Navarro

  4. Hospital Universitario Reina Sofia, Cordoba, Spain

    F. G. Martínez

  5. Hospital General de Castellon, Castellon, Spain

    J. Beltrán

  6. Hospital Universitario San Cecilio, Granada, Spain

    D. Salvatierra

  7. Hospital de Cruces, Biscay, Spain

    A. Alonso

  8. Menarini Research, Florence, Italy

    M. Ballarín,  I. Eguidazu, A. Zapata, R. Artigas & D. Mauleón

  9. Department of Biostatistics, Autonomous University, Barcelona, Spain

    M. Horas & F. Torres

  10. Menarini Research, Barcelona, Spain

    M. Ballarín,  I. Eguidazu, A. Zapata, R. Artigas & D. Mauleón

Authors
  1. J. L. Marenco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Pérez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. J. Navarro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. G. Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Beltrán
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Salvatierra
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Alonso
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Ballarín
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. I. Eguidazu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A. Zapata
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M. Horas
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. F. Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. R. Artigas
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. D. Mauleón
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. Eguidazu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marenco, J.L., Pérez, M., Navarro, F.J. et al. A Multicentre, Randomised, Double-Blind Study to Compare the Efficacy and Tolerability of Dexketoprofen Trometamol versus Diclofenac in the Symptomatic Treatment of Knee Osteoarthritis. Clin. Drug Investig. 19, 247–256 (2000). https://doi.org/10.2165/00044011-200019040-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200019040-00002

Keywords

Search

Navigation